# US 2026/0062735 A1 · Lyophilized or lyophilizable indicator master mix for nucleic acid amplification and visual detection of a biological target

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062735 A1
- Document ID: US20260062735A1
- Status: Published application
- Kind: A1
- Application number: 19/313,270
- Filed: 2025-08-28
- Published: 2026-03-05
- Earliest claimed: 2024-08-28
- Assignees: Definitive Biotechnologies LLC
- Applicants: Definitive Biotechnologies LLC
- Inventors: Timothy Alcorn; Peter Latham; Todd Haran; Scott Rosebrough
- Web page: https://patentgrep.com/patent/US20260062735A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6851: Quantitative amplification
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Indicator master mix for performing nucleic acid amplification assays to detect and visually identify the presence or absence of target or template DNA or RNA sequences. The indicator master mix comprises (i) a human readable, substantially hydrophobic nucleic-acid based indicator and (ii) a solvent configured to solubilize the substantially hydrophobic nucleic-acid based indicator, such as DMSO. The relative amount of nucleic-acid based indicator to solvent is within the range of (i) about 0.01 gm nucleic-acid based indictor/gm solvent to (ii) about 0.05 gm nucleic-acid based indicator/gm solvent. The master mix is configured to perform the nucleic acid amplification assay to detect and visually identify the presence or absence of the target or template DNA or RNA sequence, and the substantially hydrophobic nucleic-acid based indicator is visually detectable by a human eye to indicate the presence or absence of the target or template DNA or RNA sequence.

## Claims

### Claim 1

An indicator master mix for performing a nucleic acid amplification assay to detect and visually identify a presence or an absence of a target or template DNA or RNA sequence, comprising: a human readable, substantially hydrophobic nucleic-acid based indicator, and a solvent configured to solubilize the substantially hydrophobic nucleic-acid based indicator, wherein the relative amount of nucleic-acid based indicator to solvent is within the range of (i) about 0.01 gm nucleic-acid based indictor/gm solvent to (ii) about 0.05 gm nucleic-acid based indicator/gm solvent, wherein the solvent solubilizes the substantially hydrophobic nucleic-acid based indicator, the indicator master mix is configured to perform the nucleic acid amplification assay to detect and visually identify the presence or the absence of the target or template DNA or RNA sequence, and the substantially hydrophobic nucleic-acid based indicator is visually detectable by a human eye to indicate the presence or absence of the target or template DNA or RNA sequence.

### Claim 2 (depends on 1)

An indicator master mix as defined in claim 1, wherein the human readable, substantially hydrophobic nucleic-acid based indicator is configured to react to one or more diprotic cations to detect and visually identify the presence of the target or template DNA or RNA sequence.

### Claim 3 (depends on 1)

An indicator master mix as defined in claim 1, wherein the human readable, substantially hydrophobic nucleic-acid based indicator is isothermal.

### Claim 4 (depends on 1)

An indicator master mix as defined in claim 1, wherein the relative amount of nucleic-acid based indicator to solvent is within the range of (i) about 0.009 gm nucleic-acid based indictor/gm solvent to (ii) about 0.045 gm nucleic-acid based indicator/gm solvent.

### Claim 5 (depends on 1)

An indicator master mix as defined in claim 1, wherein the human readable, substantially hydrophobic nucleic-acid based indicator is quenched Calcein.

### Claim 6 (depends on 5)

An indicator master mix as defined in claim 5, wherein the solvent is an aprotic solvent.

### Claim 7 (depends on 6)

An indicator master mix as defined in claim 6, wherein the aprotic solvent is selected from the group including: Acetone, Acetonitrile, DMF (N,N-Dimethylformamide), DMSO (Dimethyl sulfoxide), DCM (Dichloromethane), THF (Tetrahydrofuran), HMF (hydroxymethylfurfural) and Crown ethers.

### Claim 8 (depends on 7)

An indicator master mix as defined in claim 7, wherein the aprotic solvent is DMSO.

### Claim 9 (depends on 1)

An indicator master mix as defined in claim 1, wherein the solvent is configured to solubilize the substantially hydrophobic nucleic-acid based indicator into an aqueous-based solution of the indicator master mix.

### Claim 10 (depends on 1)

An indicator master mix as defined in claim 1, wherein the indicator master mix is substantially dehydrated and defines a form factor configured to perform a nucleic acid amplification assay on a respective biological sample to detect and visually identify the presence of a target or template DNA or RNA sequence in the respective biological sample.

### Claim 11 (depends on 10)

An indicator master mix as defined in claim 10, wherein the indicator master mix is lyophilized.

### Claim 12 (depends on 11)

An indicator master mix as defined in claim 11, wherein the indicator master mix is formed into a plurality of lyobeads, and one or more of the lyobeads beads are configured to perform a nucleic acid amplification assay on a respective biological sample.

### Claim 13

An indicator master mix for performing a nucleic acid amplification assay to detect and visually identify a presence or an absence of a target or template DNA or RNA sequence in a biological sample, comprising: first substantially hydrophobic means for detecting and visually identifying with a human eye the presence or the absence of the target or template DNA or RNA sequence in the biological sample; and second means for solubilizing the first means, wherein the relative amount of first means to second means is within the range of (i) about 0.01 gm first means/gm second means to (ii) about 0.05 gm first means/gm second means, the indicator master mix is configured to perform the nucleic acid amplification assay to detect and visually identify the presence or the absence of the target or template DNA or RNA sequence in the biological sample, and the first means is visually detectable by the human eye to indicate the presence or the absence of the target or template DNA or RNA sequence in the biological sample.

### Claim 14 (depends on 13)

An indicator master mix as defined in claim 13, wherein the first means is a human readable, substantially hydrophobic nucleic-acid based indicator, and the second means is a solvent configured to solubilize the substantially hydrophobic nucleic-acid based indicator.

### Claim 15 (depends on 14)

An indicator master mix as defined in claim 14, wherein the human readable, substantially hydrophobic nucleic-acid based indicator is quenched Calcein, and the solvent is an aprotic solvent selected from the group including: Acetone, Acetonitrile, DMF (N,N-Dimethylformamide), DMSO (Dimethyl sulfoxide), DCM (Dichloromethane), THF (Tetrahydrofuran), HMF (hydroxymethylfurfural) and Crown ethers.

### Claim 16

A method comprising the following steps:
solubilizing a human readable, substantially hydrophobic nucleic-acid based indicator in a solvent, wherein the relative amount of nucleic-acid based indicator to solvent is within the range of (i) about 0.01 gm nucleic-acid based indictor/gm solvent to (ii) about 0.05 gm nucleic-acid based indicator/gm solvent;
combining the nucleic-acid based indicator and solvent solution with an aqueous-based solution containing a cofactor or diprotic cation containing compound and quenching the nucleic-acid based indicator in the solution; and
lyophilizing the quenched nucleic-acid based indicator solution and forming a lyophilized master mix wherein the relative amount of nucleic-acid based indicator to solvent in the lyophilized master mix is within the range of (i) about 0.01 gm nucleic-acid based indictor/gm solvent to (ii) about 0.05 gm nucleic-acid based indicator/gm solvent.

### Claim 17 (depends on 16)

A method as defined in claim 16, further comprising adding to the quenched nucleic-acid based indicator solution one or more enzymes, nucleotides, buffers, stabilizers, enhancers, primers, probes and excipients, prior to the step of lyophilizing.

### Claim 18 (depends on 17)

A method as defined in claim 17, further comprising aliquoting the master mix into a plurality of reaction vessels prior to the step of lyophilizing.

### Claim 19 (depends on 18)

A method as defined in claim 18, wherein the reaction vessels are reaction tubes, and at least a portion of each reaction tube is transparent or substantially transparent to enable visualization therethrough by a human eye to visually observe a presence or an absence of the target or template DNA or RNA sequence.

### Claim 20 (depends on 16)

A method as defined in claim 16, wherein the human readable, substantially hydrophobic nucleic-acid based indicator is Calcein, and the cofactor or diprotic cation containing compound is manganese chloride (MnCl2).

### Claim 21

A method comprising the following steps:
hydrating a lyophilized indicator master mix with a processed biological sample, wherein the lyophilized master mix contains a quenched nucleic-acid based indicator and a solvent and the relative amount of nucleic-acid based indicator to solvent is within the range of (i) about 0.01 gm nucleic-acid based indictor/gm solvent to (ii) about 0.05 gm nucleic-acid based indicator/gm solvent; and
visually observing the appearance of the hydrated master mix and biological sample with a human eye and detecting with the human eye a presence or an absence of a target or template DNA or RNA sequence.

### Claim 22 (depends on 21)

A method as defined in claim 21, further comprising incubating the hydrated master mix and biological sample at a substantially constant temperature for a substantially predetermined period of time prior to visually observing the appearance of the hydrated master mix and biological sample and then visually detecting the presence or the absence of the target or template DNA or RNA sequence.

### Claim 23 (depends on 22)

A method as defined in claim 22, wherein the human readable, substantially hydrophobic nucleic-acid based indicator is Calcein, and the solvent is selected from the group including Acetone, Acetonitrile, DMF (N,N-Dimethylformamide), DMSO (Dimethyl sulfoxide), DCM (Dichloromethane), THF (Tetrahydrofuran), HMF (hydroxymethylfurfural) and Crown ethers.
